申请人:Xu Rongzhen
公开号:US20130178470A1
公开(公告)日:2013-07-11
The present invention relates to a novel berbamine derivative of formula I or a pharmaceutically acceptable salt thereof, a process for preparation of the same, a pharmaceutical composition comprising said compound and its use in manufacture of an antitumor medicament.
本发明涉及一种具有化学式I的新型贝巴明衍生物或其药用盐,以及制备该衍生物的方法,包括所述化合物的药物组合物及其在制造抗肿瘤药物中的应用。